Quantitative measurement of IgG to SARS-CoV-2 proteins using ImmunoCAP

BACKGROUND: Detailed understanding of the immune response to SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), has been hampered by a lack of quantitative antibody assays. OBJECTIVE: To develop a quantitative assay for IgG to SARS-CoV-2 proteins that could readily be implemented in clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Keshavarz, Behnam, Wiencek, Joesph R., Workman, Lisa J., Straesser, Matthew D., Muehling, Lyndsey M., Canderan, Glenda, Drago, Fabrizio, Bonham, Catherine A., Sturek, Jeffrey M., Ramani, Chintan, McNamara, Coleen A., Woodfolk, Judith A., Kadl, Alexandra, Platts-Mills, Thomas A.E., Wilson, Jeffrey M.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7668760/
https://ncbi.nlm.nih.gov/pubmed/33200147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.11.09.20228411
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados